INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

IMAImageneBio, Inc.

CIK 0001835579

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score27
Connections4with evidence

IMA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GY
Grant-Huerta YaninaChief Financial Officer
IMAImageneBio, Inc.
Grant or award
A—
65.0K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Grant-Huerta YaninaChief Financial Officer · Aug 17, 2026
  • ← Insider ofevidence
    Butler ErinPrincipal Accounting Officer · Jan 2, 2026
  • ← Insider ofevidence
    Wang Stephen HuiDirector · Dec 22, 2025
21
GY
Grant-Huerta YaninaChief Financial Officer
IMAImageneBio, Inc.
Grant or award
A
—
39.0K sh
Aug 14, 2026
Aug 17, 2026
traded Aug 14, 2026
+3d
SEC FORM 4

Evidence

9
GY
Grant-Huerta YaninaChief Financial Officer
IMAImageneBio, Inc.
Grant or award
A—
56.0K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC FORM 4

Evidence

27
BE
Butler ErinPrincipal Accounting Officer
IMAImageneBio, Inc.
Grant or award
A—
22.5K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC FORM 4

Evidence

15
BE
Butler ErinPrincipal Accounting Officer
IMAImageneBio, Inc.
Grant or award
A—
22.5K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC FORM 4

Evidence

9
WH
Wang Stephen HuiDirector
IMAImageneBio, Inc.
Grant or award
A—
31.2K sh
Dec 18, 2025Dec 22, 2025
traded Dec 18, 2025
+4dSEC FORM 4

Evidence